Results 91 to 100 of about 17,905 (230)

Candida infections, causes, targets and resistance mechanisms. Traditional and alternative antifungal agents [PDF]

open access: yes, 2013
The genus Candida includes about 200 different species, but only a few species are human opportunistic pathogens and cause infections when the host becomes debilitated or immunocompromised. Candida infections can be superficial or invasive.
Leonardi, Darío   +1 more
core   +3 more sources

Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication

open access: yesBMC Infectious Diseases, 2018
Background To compare the risk of severe hepatotoxicity with anidulafungin versus caspofungin and micafungin in hospitalized adults. Methods This retrospective cohort study combined data from two large US- based hospital electronic medical record ...
Francis Vekeman   +11 more
doaj   +1 more source

Candida auris in Heart Transplant Donor: First Isolation in a Southern Italy Heart Transplant Center

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
Timeline of infection control in a heart transplant from a donor colonized with Candida auris: from detection at retrieval to strict isolation, antifungal prophylaxis, negative follow‐up cultures, and successful prevention of transmission. ABSTRACT Candida auris is an emerging multidrug‐resistant fungal pathogen increasingly implicated in healthcare ...
Lorenzo Giovannico   +6 more
wiley   +1 more source

Efficacy and safety of micafungin in empiric and D-index-guided early antifungal therapy for febrile neutropenia; A subgroup analysis of the CEDMIC trial

open access: yesInternational Journal of Infectious Diseases, 2020
Objectives: The D-index is defined as the area over the neutrophil curve during neutropenia. The CEDMIC trial confirmed the noninferiority of D-index-guided early antifungal therapy (DET) using micafungin to empirical antifungal therapy (EAT).
Shun-ichi Kimura   +18 more
doaj   +1 more source

Endoscopic Treatment of Boerhaave Syndrome Related Empyema

open access: yesRespirology Case Reports, Volume 14, Issue 1, January 2026.
Boerhaave syndrome is associated with high mortality and morbidity rates. It can lead to complications such as empyema. Endoscopic repair can be a viable, less invasive alternative to surgical repair, which is associated with a substantial degree of surgical risks. ABSTRACT Empyema and Boerhaave syndrome are both life‐threatening conditions. We present
Christopher Chan   +4 more
wiley   +1 more source

Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: A retrospective study [PDF]

open access: yes, 2016
_Background:_ In critically ill patients the incidence of invasive fungal infections caused by Candida spp. has increased remarkably. Echinocandins are recommended as initial treatment for invasive fungal infections. The safety and efficacy of micafungin
Geest, P.J. (Patrick) van der   +3 more
core   +5 more sources

Successful voriconazole treatment of invasive pulmonary aspergillosis in a patient with acute biphenotypic leukemia [PDF]

open access: yes, 2009
A 23-year old woman with acute biphenotypic leukemia (ABL) complained of chest pain with cough, high fever and hemoptysis during induction chemotherapy, although she had been treated with anti-biotics and micafungin.
Hirano, Teiichi   +9 more
core   +1 more source

Emerging Frontiers in Clinical Mycology: Innovations, Insights, and Impacts

open access: yesMycoses, Volume 69, Issue 1, January 2026.
ABSTRACT The Mycoses Study Group Education and Research Consortium (MSGERC)—a group comprising clinicians, researchers, patients, and industry partners—meets every 2 years to review the most significant challenges facing the clinical mycology community and plan research, education, and advocacy strategies to prevent fungal infections and improve ...
A. Apostolopoulou   +7 more
wiley   +1 more source

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - review of the literature

open access: yesEuropean Journal of Medical Research, 2011
Echinocandins represent the newest class of antifungal agents. Currently, three echinocandins, anidulafungin, caspofungin and micafungin are licensed for clinical use in various indications.
Kofla G, Ruhnke M
doaj   +1 more source

Atherosclerosis V, Proceeding of the Fifth International Symposium, A.M. Gotto, L.C. Smith, B. Allen, Spring Verlag, 1979(BOOK REVIEW) [PDF]

open access: yes, 2016
Antiviral effect of micafungin on three strains of human rhinoviruses. H1HeLa cells were infected with human rhinovirus type 14 (A), 21 (B), or 71 (C) (100 CCID50) and immediately treated with indicated concentrations of micafungin.
Chong-Kyo Lee (3525263)   +16 more
core   +3 more sources

Home - About - Disclaimer - Privacy